Oxeon

VC New York, United States · Founded 2011

Oxeon invests in early-stage healthcare companies and incubates new concepts through its venture studio, leveraging its extensive executive search network to build high-performing leadership teams that drive valuation growth and transform care delivery.

About Oxeon

Oxeon is a healthcare-focused investment and operating firm with deep DNA in healthcare services and provider-facing businesses, perhaps best known for combining executive search and venture investing under one roof. The firm has historically partnered with healthcare entrepreneurs at the formation and early-growth stages, often co-founding companies and placing senior operators alongside its investments. Sub-vertical exposure spans value-based care, payer and provider services, specialty care platforms, care navigation, and increasingly tech-enabled services with AI-augmented operations. Check sizes are typically in the seed and Series A range, plausibly $1M to $10M, often deployed alongside larger financial leads, with the differentiated value being the talent-and-operator network rather than capital scale. For healthcare founders, Oxeon is most relevant if you are building a US healthcare services or services-enabled software business that genuinely benefits from senior executive recruiting muscle, payer relationship depth and structured operational support. The firm is poorly suited for life-sciences therapeutics, capital-intensive devices, consumer wellness or international-only plays. Founders should expect a process that intertwines investment evaluation with talent diligence, and should be prepared to discuss exec hiring needs alongside product and market questions. Entry is best via warm introductions from existing Oxeon portfolio CEOs, healthcare bankers, or senior healthcare operators in the firm’s network; cold outbound via the website is workable but should lead with a specific articulation of where the talent-and-capital combination unlocks growth. Confirm fund stage, check size, board posture and search-engagement expectations early in conversations.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Oxeon

Tools made by companies in Oxeon's portfolio that we cover in the directory.

BrightHeart View Classifier
BrightHeart
Cardiology AI
BrightHeart's B-Right AI Platform, including the B-Right Views tool, provides AI-powered guidance and analysis for prenatal ultrasound exams, enhancing the detection of congenital heart defects and ensuring exam completeness.
PeraServer and PeraTrend
PeraHealth
Clinical Decision Support & Reference
PeraHealth's PeraServer and PeraTrend, powered by the Rothman Index, offer FDA-cleared predictive analytics for real-time patient acuity, enabling early detection of deterioration and improved clinical outcomes.
Fetal EchoScan
Brightheart
Cardiology AI
Brightheart's Fetal EchoScan is an FDA-cleared AI-powered ultrasound screening software that assists clinicians in the prenatal detection of congenital heart defects, ensuring comprehensive exams and optimizing workflow.

Portfolio companies in our directory

Other portfolio companies

Companies in Oxeon's portfolio not currently in our directory.

Team

Sonia Millsom
CEO
LinkedIn
Trevor Price
Founder & Chairman
LinkedIn
Patrick Sullivan
Partner, Executive Search
LinkedIn
Tom Keefe
Partner, Executive Search
LinkedIn
Reena Pande
Partner, Executive Search
LinkedIn

Pitch / review this investor

Have you raised from Oxeon? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.